Chemotherapy versus Hormonal Therapy in Advanced Breast Carcinoma
- 23 October 1986
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 315 (17) , 1092-1093
- https://doi.org/10.1056/nejm198610233151712
Abstract
Correspondence from The New England Journal of Medicine — Chemotherapy versus Hormonal Therapy in Advanced Breast CarcinomaKeywords
This publication has 11 references indexed in Scilit:
- A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia.Journal of Clinical Oncology, 1986
- A Randomized Trial of Chemotherapy and Hormonal Therapy in Advanced Breast CancerNew England Journal of Medicine, 1985
- Reporting Results From Chemotherapy TrialsPublished by American Medical Association (AMA) ,1984
- Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group StudyCancer, 1984
- Monoclonal antibodies localize oestrogen receptor in the nuclei of target cellsNature, 1984
- Comparing survival of responders and nonresponders after treatment: A potential source of confusion in interpreting cancer clinical trialsControlled Clinical Trials, 1983
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983
- Analysis of survival by tumor response.Journal of Clinical Oncology, 1983
- Reflections on medical oncology: an appeal for better clinical trials and improved reporting of their results.Journal of Clinical Oncology, 1983
- An uncontrolled clinical trial—treatment response or spontaneous improvement?Controlled Clinical Trials, 1982